inzirqo
Generic: hydrochlorothiazide
Labeler: ani pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
inzirqo
Generic Name
hydrochlorothiazide
Labeler
ani pharmaceuticals, inc.
Dosage Form
POWDER, FOR SUSPENSION
Routes
Active Ingredients
hydrochlorothiazide 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70954-522
Product ID
70954-522_d6ace9b2-f8fa-42b9-8338-9e2b5519ef6b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA219141
Listing Expiration
2026-12-31
Marketing Start
2025-01-30
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70954522
Hyphenated Format
70954-522
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
inzirqo (source: ndc)
Generic Name
hydrochlorothiazide (source: ndc)
Application Number
NDA219141 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 80 mL in 1 BOTTLE (70954-522-10)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d6ace9b2-f8fa-42b9-8338-9e2b5519ef6b", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0370954522102"], "unii": ["0J48LPH2TH"], "rxcui": ["2704012", "2704018"], "spl_set_id": ["41aaea48-6c1b-42c8-a96f-5923d49dc934"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "80 mL in 1 BOTTLE (70954-522-10)", "package_ndc": "70954-522-10", "marketing_start_date": "20250130"}], "brand_name": "INZIRQO", "product_id": "70954-522_d6ace9b2-f8fa-42b9-8338-9e2b5519ef6b", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "70954-522", "generic_name": "hydrochlorothiazide", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INZIRQO", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "10 mg/mL"}], "application_number": "NDA219141", "marketing_category": "NDA", "marketing_start_date": "20250130", "listing_expiration_date": "20261231"}